Black Swan Analysis limited

Formed in 2007, Black Swan Analysis is devoted exclusively to delivering high-quality epidemiology data, data analysis, forecast modeling and market research within the healthcare sector which generates insightful outputs that makes business decisions clear for our clients. Our understanding of patient epidemiology, forecasting and wealth of experience on the industry side has been a true differentiator for us and an asset to both the company and our clients. It delivers that level of confidence to our client that ultimately translates into a quality output in every aspect of our service. Consistently delivering above our client’s expectations, this has solidified long-term relationships with many of our customers.

Access to our proprietary pricing and disease epidemiology database and reports, coupled with our commercial disease experience, makes us a valuable and ideal partner for any healthcare or pharmaceutical company looking to evaluate a disease area or commercialize their products.

Research Reports By Black Swan Analysis limited

Found 151 publications
Hearing Loss Forecast in 12 Major Markets 2017-2027 US$ 6,150.00 Feb, 2017 48 pages
Liver Cancer Forecast in 18 Major Markets 2017-2027 US$ 6,150.00 Feb, 2017 64 pages
1 2 3 4
Skip to top

Analytics & News by Black Swan Analysis limited